# B/F/TAF Switch Study for HIV-HBV Coinfection

> **NCT03797014** · PHASE4 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 28 (actual)

## Conditions studied

- HIV-1-infection
- Hepatitis B

## Interventions

- **DRUG:** B/F/TAF

## Key facts

- **NCT ID:** NCT03797014
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-30
- **Primary completion:** 2022-11-22
- **Final completion:** 2023-05-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03797014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03797014, "B/F/TAF Switch Study for HIV-HBV Coinfection". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03797014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*